|
1
|
Kanis JA, Melton LJ III, Christiansen C,
Johnston CC and Khaltaev N: The diagnosis of osteoporosis. J Bone
Miner Res. 9:1137–1141. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Consensus development conference:
Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med.
94:646–650. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mediati RD, Vellucci R and Dodaro L:
Pathogenesis and clinical aspects of pain in patients with
osteoporosis. Clin Cases Miner Bone Metab. 11:169–172.
2014.PubMed/NCBI
|
|
4
|
Nagae M, Hiraga T, Wakabayashi H, Wang L,
Iwata K and Yoneda T: Osteoclasts play a part in pain due to the
inflammation adjacent to bone. Bone. 39:1107–1115. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Roth T, Kammerlander C, Gosch M, Luger TJ
and Blauth M: Outcome in geriatric fracture patients and how it can
be improved. Osteoporos Int. 21 Suppl 4:S615–S619. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rosen CJ: Clinical practice.
Postmenopausal osteoporosis. N Engl J Med. 353:595–603. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McCormick RK: Osteoporosis: Integrating
biomarkers and other diagnostic correlates into the management of
bone fragility. Altern Med Rev. 12:113–145. 2007.PubMed/NCBI
|
|
8
|
Vasikaran S, Eastell R, Bruyère O, Foldes
AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S,
Trenti T, et al: Markers of bone turnover for the prediction of
fracture risk and monitoring of osteoporosis treatment: A need for
international reference standards. Osteoporos Int. 22:391–420.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kassahun K, McIntosh I, Koeplinger K, Sun
L, Talaty JE, Miller DL, Dixon R, Zajic S and Stoch SA: Disposition
and metabolism of the cathepsin K inhibitor odanacatib in humans.
Drug Metab Dispos. 42:818–827. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li X, Ominsky MS, Niu QT, Sun N, Daugherty
B, D'Agostin D, Kurahara C, Gao Y, Cao J, Gong J, et al: Targeted
deletion of the sclerostin gene in mice results in increased bone
formation and bone strength. J Bone Miner Res. 23:860–869. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang H, Yoshiko Y, Yamamoto R, Minamizaki
T, Kozai K, Tanne K, Aubin JE and Maeda N: Overexpression of
fibroblast growth factor 23 suppresses osteoblast differentiation
and matrix mineralization in vitro. J Bone Miner Res. 23:939–948.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Li L, Moore BT, Peng XH, Fang X,
Lappe JM, Recker RR and Xiao P: MiR-133a in human circulating
monocytes: A potential biomarker associated with postmenopausal
osteoporosis. PLoS One. 7:e346412012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao Z, Moore BT, Wang Y, Peng XH, Lappe
JM, Recker RR and Xiao P: MiR-422a as a potential cellular microRNA
biomarker for postmenopausal osteoporosis. PLoS One. 9:e970982014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cahill DJ: Protein and antibody arrays and
their medical applications. J Immunol Methods. 250:81–91. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Senior K: Fingerprinting disease with
protein chip arrays. Mol Med Today. 5:326–327. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Austen BM, Frears ER and Davies H: The use
of seldi proteinchip arrays to monitor production of Alzheimer's
betaamyloid in transfected cells. J Pept Sci. 6:459–469. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park SB, Lee YJ and Chung CK: Bone Mineral
Density Changes after Ovariectomy in Rats as an Osteopenic Model:
Stepwise Description of Double Dorso-Lateral Approach. J Korean
Neurosurg Soc. 48:309–312. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yoshie O, Imai T and Nomiyama H:
Chemokines in immunity. Adv Immunol. 78:57–110. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Imai T, Hieshima K, Haskell C, Baba M,
Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ
and Yoshie O: Identification and molecular characterization of
fractalkine receptor CX3CR1, which mediates both leukocyte
migration and adhesion. Cell. 91:521–530. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fong AM, Robinson LA, Steeber DA, Tedder
TF, Yoshie O, Imai T and Patel DD: Fractalkine and CX3CR1 mediate a
novel mechanism of leukocyte capture, firm adhesion and activation
under physiologic flow. J Exp Med. 188:1413–1419. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Han KH, Ryu JW, Lim KE, Lee SH, Kim Y,
Hwang CS, Choi JY and Han KO: Vascular expression of the chemokine
CX3CL1 promotes osteoclast recruitment and exacerbates bone
resorption in an irradiated murine model. Bone. 61:91–101. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Koizumi K, Saitoh Y, Minami T, Takeno N,
Tsuneyama K, Miyahara T, Nakayama T, Sakurai H, Takano Y and
Nishimura M: Role of CX3CL1/fractalkine in osteoclast
differentiation and bone resorption. J Immunol. 183:7825–7831.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hoshino A, Ueha S, Hanada S, Imai T, Ito
M, Yamamoto K, Matsushima K, Yamaguchi A and Iimura T: Roles of
chemokine receptor CX3CR1 in maintaining murine bone homeostasis
through the regulation of both osteoblasts and osteoclasts. J Cell
Sci. 126:1032–1045. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen YD, Huang CY, Liu HY, Yao WF, Wu WG,
Lu YL and Wang W: Serum CX3CL1/fractalkine concentrations are
positively associated with disease severity in postmenopausal
osteoporotic patients. Br J Biomed Sci. 73:121–128. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rifas L, Fausto A, Scott MJ, Avioli LV and
Welgus HG: Expression of metalloproteinases and tissue inhibitors
of metalloproteinases in human osteoblast-like cells:
Differentiation is associated with repression of metalloproteinase
biosynthesis. Endocrinology. 134:213–221. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Murphy E, Roux-Lombard P, Rooney T,
Fitzgerald O, Dayer JM and Bresnihan B: Serum levels of tissue
inhibitor of metalloproteinase-1 and periarticular bone loss in
early rheumatoid arthritis. Clin Rheumatol. 28:285–291. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stanojkovic I, Kotur-Stevuljevic J, Spasic
S, Milenkovic B, Vujic T, Stefanovic A and Ivanisevic J:
Relationship between bone resorption, oxidative stress and
inflammation in severe COPD exacerbation. Clin Biochem.
46:1678–1682. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ginaldi L, Di Benedetto MC and De Martinis
M: Osteoporosis, inflammation and ageing. Immun Ageing. 2:142005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Luo XH, Guo LJ, Shan PF, Xie H, Wu XP,
Zhang H, Cao XZ, Yuan LQ and Liao EY: Relationship of circulating
MMP-2, MMP-1, and TIMP-1 levels with bone biochemical markers and
bone mineral density in postmenopausal Chinese women. Osteoporos
Int. 17:521–526. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Eraltan H, Cacina C, Kahraman OT, Kurt O,
Aydogan HY, Uyar M, Can A and Cakmakoğlu B: MCP-1 and CCR2 gene
variants and the risk for osteoporosis and osteopenia. Genet Test
Mol Biomarkers. 16:229–233. 2012. View Article : Google Scholar : PubMed/NCBI
|
